Your Questions, Answered

We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.

Filter by topic:

Replace the adhesive patch after 24 hours of use or any time that the transmitter is removed and replaced. Repeated removal and replacement may reduce adhesion strength.

The Eversense® 365 Sensor and adhesive patches contain silicone. If you have any concerns about allergic reaction to silicones, contact your health care professional prior to use.

The Eversense® 365 CGM System components and accessories are not made with natural rubber latex. They are considered latex free.

different indicator lights.png

different indicator lights 1.png

By setting the snooze alert, you can set how often an alert repeats after you have received a Low Glucose and High Glucose alert. The Low Glucose alert repeat interval can be adjusted from 5 minutes up to 30 minutes. The High Glucose alert repeat interval can be adjusted from 15 minutes up to 180 minutes.

1. Tap Menu > Settings > Sound Settings to display the SOUND SETTINGS screen.

2. Tap each snooze alert to set how often the alert repeats. Tap Done when complete.

sound setting 2.png sound setting 3.png

Events can be added later from the MY GLUCOSE screen with a single tap anywhere on the graph area. You will be able to adjust the date and time of the event.

Still have questions?

The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

MKT-001692 Rev 1